SIRT1 and pancreatic neoplasm: Compound AC-93253 and Salermide (chosen at a concentration at which SIRT-2, but not SIRT-1, is inhibited) blocked cell proliferation and downregulated the c-Myc and N-Myc oncoproteins in neuroblastoma and in pancreatic cancer [91].